Lord Lebedev

In 2018, the United Kingdom’s Chief Medical Officer commissioned independent researchers at University College London to map published research on screen time, social media, and children and young people’s mental health. Their findings were published by the National Institute for Health Research.

On 7 February 2019, the Chief Medical Officer published a commentary on this research, alongside their advice for parents and carers, and their recommendations for other stakeholders. They determined that the evidence was insufficiently conclusive to support the Chief Medical Officer’s evidence-based guidelines on optimal amounts of screen use or online activities, such as social media use.

Ketamine does not have a marketing authorisation in the United Kingdom for use in the treatment of any mental health conditions. Esketamine nasal spray, an isomer of ketamine, is licensed for treatment-resistant depression that has not responded to at least two different antidepressants in the current moderate to severe depressive episode in adults, and for the treatment of adults with a moderate to severe episode of major depressive disorder, as acute short-term treatment for the rapid reduction of depressive symptoms, which, according to clinical judgement, constitutes a psychiatric emergency.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new, licenced medicines represent a clinically and cost-effective use of resources.

The NICE has been unable to recommend esketamine for treatment-resistant depression due to uncertainties in its clinical and cost-effectiveness. It is not therefore routinely funded by the NHS in England for any indication.

The NICE was unable to make recommendations on the use of esketamine nasal spray for the treatment of major depressive disorder because the marketing authorisation holder did not provide an evidence submission.

The Government is making reforms to better support victims of child sexual abuse and prioritise their rights, including making it easier for victims to pursue compensation claims in the civil court.

The Government has included a measure in the Crime and Policing Bill to remove the three-year time limit for victims to bring civil personal injury child sexual abuse claims, so that claims do not need to be brought within three years of turning 18. This change is significant because we know that it can take decades for survivors to disclose sexual abuse.

Victims, including children, who suffer a serious physical or mental injury as a direct result of a violent crime such as physical and sexual abuse, may also be able to access compensation under the Criminal Injuries Compensation Scheme. Payments under the Scheme are an expression of public sympathy and are intended to be an acknowledgment of the harm that eligible applicants have experienced.

The Criminal Injuries Compensation Authority (CICA) has worked to improve its service for compensation applicants, including providing its staff with specific training on the impact of psychological and emotional trauma in sexual abuse cases, and guidance on applying the exceptional circumstances discretion to sexual abuse cases - particularly child sexual abuse.